MIND Neuroscience Prize
Forecasted
MIND Neuroscience Prize supports early-to-mid-career investigators pursuing bold, hypothesis-driven brain research to advance understanding, prevention, and treatment of neurodegenerative diseases.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2027 (LOI deadline)
Funding Amounts: $750,000 over three years ($250,000 annually); generally at least six prizes annually
Summary: Supports bold, hypothesis-driven neuroscience research that advances understanding, prediction, prevention, and treatment of neurodegenerative diseases.
Key Information: Applicants need an MD, PhD, MD-PhD, or equivalent and one to eight years of independent research experience at a U.S. research institution.
Description
The Pershing Square Foundation’s MIND (Maximizing Innovation in Neuroscience Discovery) Prize supports early-to-mid-career investigators pursuing radically innovative, scientifically sound research on the brain and cognition. It seeks high-risk, high-reward projects with transformative potential, including work considered too speculative for traditional funding. Proposals with a clear application to neurodegenerative and neurocognitive disorders, particularly Alzheimer’s disease and dementias, are favored.
The prize encourages interdisciplinary approaches and collaboration across departments and institutions. Research may include neurobiology, brain imaging and mapping, machine learning, drug delivery, or synthetic biology. Projects can develop novel tools or technologies when these test a clearly defined biological hypothesis, or pursue approaches with extraordinary therapeutic potential. Investigators with or without a core neuroscience background are encouraged to apply.
